Body, Jean-Jacques <br/><br/>
An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countries.  [electronic resource] 

 -  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer  09 2017 
 - 2823-2832 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1433-7339 
<br/><br/><label>Standard No.: </label>10.1007/s00520-017-3697-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Bone Density Conservation Agents--administration & dosage<br/>Bone Neoplasms--drug therapy<br/>Denosumab--administration & dosage<br/>Diphosphonates--administration & dosage<br/>Europe<br/>Female<br/>Humans<br/>Imidazoles--administration & dosage<br/>Infusions, Intravenous<br/>Injections, Subcutaneous<br/>Male<br/>Time and Motion Studies<br/>Zoledronic Acid